Published in Schizophr Res on April 01, 2004
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull (2007) 2.56
Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull (2005) 2.50
Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry (2009) 2.25
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry (2009) 2.17
Psychiatry as a clinical neuroscience discipline. JAMA (2005) 2.00
Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program. Am J Psychiatry (2015) 1.75
Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull (2006) 1.54
Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research. Schizophr Bull (2012) 1.50
Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk". Schizophr Res (2005) 1.48
Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull (2008) 1.44
Lithium suppression of tau induces brain iron accumulation and neurodegeneration. Mol Psychiatry (2016) 1.38
Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability. Schizophr Bull (2005) 1.38
Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry (2010) 1.36
Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull (2011) 1.36
Social functioning in individuals at clinical high risk for psychosis. Schizophr Res (2007) 1.34
Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychol Med (2013) 1.34
Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull (2008) 1.32
Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res (2012) 1.32
Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res (2007) 1.32
Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull (2009) 1.29
The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol Med (2010) 1.25
At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull (2012) 1.24
Social functioning in young people at risk for schizophrenia. Psychiatry Res (2007) 1.23
Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull (2010) 1.23
Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology (2010) 1.22
Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry (2013) 1.20
The phenomenological critique and self-disturbance: implications for ultra-high risk ("prodrome") research. Schizophr Bull (2007) 1.16
Self-report of attenuated psychotic experiences in a college population. Schizophr Res (2007) 1.15
Prediction and prevention of schizophrenia: what has been achieved and where to go next? World Psychiatry (2011) 1.15
The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res (2010) 1.14
Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophr Res (2008) 1.13
Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother (2010) 1.10
Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension. Ann Gen Psychiatry (2010) 1.07
Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study. Schizophr Res (2013) 1.06
Cerebellar networks in individuals at ultra high-risk of psychosis: impact on postural sway and symptom severity. Hum Brain Mapp (2014) 1.06
Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience (2013) 1.05
Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World Psychiatry (2011) 1.04
White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study. Schizophr Bull (2013) 1.04
Emotion recognition in individuals at clinical high-risk for schizophrenia. Schizophr Bull (2011) 1.04
Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophr Bull (2008) 1.03
Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophr Res (2013) 1.02
Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic. J Clin Psychiatry (2012) 1.00
Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med (2012) 1.00
CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS One (2007) 0.99
Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev Psychopathol (2013) 0.99
Assessment of cognitive insight: a qualitative review. Schizophr Bull (2010) 0.99
Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res (2008) 0.96
Kraepelin and psychotic prodromal conditions. Eur Arch Psychiatry Clin Neurosci (2008) 0.96
Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study. Nat Commun (2015) 0.92
Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables. Schizophr Bull (2013) 0.92
Recent approaches to psychological interventions for people at risk of psychosis. Eur Arch Psychiatry Clin Neurosci (2006) 0.91
Cognitive function and symptoms in adolescents with schizotypal personality disorder. Schizophr Bull (2006) 0.91
Cerebellar Morphology and Procedural Learning Impairment in Neuroleptic-Naive Youth at Ultrahigh Risk of Psychosis. Clin Psychol Sci (2014) 0.90
Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence. Can J Psychiatry (2014) 0.90
Substantial genetic overlap between schizotypy and neuroticism: a twin study. Behav Genet (2012) 0.89
Insular volume abnormalities associated with different transition probabilities to psychosis. Psychol Med (2011) 0.89
The development of psychotic disorders in adolescence: a potential role for hormones. Horm Behav (2013) 0.88
Evaluating and treating the prodromal stage of schizophrenia. Curr Psychiatry Rep (2004) 0.88
Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population. Schizophr Bull (2013) 0.88
"Attenuated psychotic symptoms syndrome" as a risk syndrome of psychosis, diagnosis in DSM-V: The debate. Indian J Psychiatry (2011) 0.88
Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull (2012) 0.87
Predicting the risk of psychosis onset: advances and prospects. Early Interv Psychiatry (2012) 0.87
Prediction of conversion to psychosis: review and future directions. Rev Bras Psiquiatr (2011) 0.87
An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.87
EEG: a helpful tool in the prediction of psychosis. Eur Arch Psychiatry Clin Neurosci (2009) 0.87
Reasons for cannabis use among youths at ultra high risk for psychosis. Early Interv Psychiatry (2013) 0.87
Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model? Can J Psychiatry (2016) 0.86
Abnormal movements are associated with poor psychosocial functioning in adolescents at high risk for psychosis. Schizophr Res (2011) 0.86
Childhood onset diagnoses in a case series of teens at clinical high risk for psychosis. J Child Adolesc Psychopharmacol (2009) 0.86
Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs. Schizophr Bull (2012) 0.85
Olfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection. Int J Psychophysiol (2013) 0.85
The Palau Early Psychosis Study: distribution of cases by level of genetic risk. Am J Med Genet B Neuropsychiatr Genet (2007) 0.85
Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis. Psychol Med (2013) 0.84
Handwriting analysis indicates spontaneous dyskinesias in neuroleptic naïve adolescents at high risk for psychosis. J Vis Exp (2013) 0.84
Spontaneous parkinsonisms and striatal impairment in neuroleptic free youth at ultrahigh risk for psychosis. NPJ Schizophr (2015) 0.83
Developing services for the early detection of psychosis: a critical consideration of the current state of the art. Eur Child Adolesc Psychiatry (2006) 0.83
Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research. Front Hum Neurosci (2015) 0.82
Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis. Early Interv Psychiatry (2007) 0.82
Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Interv Psychiatry (2014) 0.82
Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Res (2013) 0.81
The concept of psychosis: historical and phenomenological aspects. Schizophr Bull (2008) 0.81
Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study. Psychiatry Investig (2009) 0.81
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis. Neuropsychopharmacology (2014) 0.81
Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers. Transl Psychiatry (2016) 0.81
Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis. Schizophr Res (2012) 0.80
Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. Transl Psychiatry (2013) 0.80
A Personality Disorders: Schizotypal, Schizoid and Paranoid Personality Disorders in Childhood and Adolescence. J Psychopathol Behav Assess (2010) 0.80
A survey of psychosis risk symptoms in Kenya. Compr Psychiatry (2011) 0.80
Treating early psychosis: who, what, and when? Dialogues Clin Neurosci (2005) 0.79
A Transdiagnostic Network Approach to Psychosis. Schizophr Bull (2016) 0.79
The occurrence and nature of early signs of schizophrenia and psychotic mood disorders among former child and adolescent psychiatric patients followed into adulthood. Child Adolesc Psychiatry Ment Health (2008) 0.79
Gender difference in the prodromal symptoms of first-episode schizophrenia. J Korean Med Sci (2009) 0.79
Does a parent-report measure of behavioral problems enhance prediction of conversion to psychosis in clinical high-risk adolescents? Schizophr Res (2011) 0.79
Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophr Res (2015) 0.78
Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function. Schizophr Res (2015) 0.78
Ten-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis. BMC Psychiatry (2014) 0.77
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry (2005) 5.17
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry (2002) 4.06
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 3.86
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry (2006) 3.62
Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry (2008) 2.89
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull (2007) 2.56
Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res (2008) 2.45
Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. J Clin Psychiatry (2012) 2.31
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull (2005) 2.13
The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull (2003) 2.05
Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatry (2013) 2.02
Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale. Aust N Z J Psychiatry (2012) 2.02
Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res (2009) 1.98
Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull (2009) 1.85
Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry (2005) 1.84
Australian mental health reform: time for real outcomes. Med J Aust (2005) 1.81
Vocational intervention in first-episode psychosis: individual placement and support v. treatment as usual. Br J Psychiatry (2008) 1.74
PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust (2007) 1.72
Pituitary volume in psychosis. Br J Psychiatry (2004) 1.70
Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry (2009) 1.70
Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry (2003) 1.67
Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry (2006) 1.62
Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull (2006) 1.54
The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophr Res (2009) 1.46
Psychological needs of adolescents in the early phase of bipolar disorder: implications for early intervention. Early Interv Psychiatry (2011) 1.46
Pilot study evaluating the effect of massage therapy on stress, anxiety and aggression in a young adult psychiatric inpatient unit. Aust N Z J Psychiatry (2008) 1.46
Childhood trauma and psychotic disorders: a systematic, critical review of the evidence. Schizophr Bull (2007) 1.45
Guidelines for youth depression: time to incorporate new perspectives. Med J Aust (2010) 1.39
Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res (2006) 1.38
Funding for mental health research: the gap remains. Med J Aust (2011) 1.38
Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability. Schizophr Bull (2005) 1.38
Increased access to evidence-based primary mental health care: will the implementation match the rhetoric? Med J Aust (2007) 1.36
Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull (2008) 1.32
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull (2010) 1.32
Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophr Bull (2003) 1.30
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry (2011) 1.30
Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry (2005) 1.24
Two-year stability of personality disorder in older adolescent outpatients. J Pers Disord (2004) 1.23
Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res (2007) 1.23
Recognition of depression and psychosis by young Australians and their beliefs about treatment. Med J Aust (2005) 1.23
Development and evaluation of a youth mental health community awareness campaign - The Compass Strategy. BMC Public Health (2006) 1.22
Non-reduction in hippocampal volume is associated with higher risk of psychosis. Schizophr Res (2002) 1.20
The initial prodrome to bipolar affective disorder: prospective case studies. J Affect Disord (2003) 1.18
The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord (2007) 1.17
Influence of gender on mental health literacy in young Australians. Aust N Z J Psychiatry (2006) 1.17
Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry (2007) 1.17
The phenomenological critique and self-disturbance: implications for ultra-high risk ("prodrome") research. Schizophr Bull (2007) 1.16
Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. Br J Psychiatry (2008) 1.14
Predictors of vocational recovery among young people with first-episode psychosis: findings from a randomized controlled trial. Psychiatr Rehabil J (2012) 1.14
Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry (2007) 1.14
Screening for borderline personality disorder in outpatient youth. J Pers Disord (2008) 1.14
Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol Psychiatry (2008) 1.14
Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry (2003) 1.14
Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp (2008) 1.14
Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group. Aust N Z J Psychiatry (2002) 1.14
Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry (2010) 1.13
Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis. J Clin Psychiatry (2009) 1.13
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr Res (2006) 1.11
Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry (2012) 1.11
Pre-emptive intervention in psychosis: agnostic rather than diagnostic. Aust N Z J Psychiatry (2011) 1.10
Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res (2009) 1.10
Internet-based interventions for psychosis: a sneak-peek into the future. Psychiatr Clin North Am (2012) 1.09
White matter volume changes in people who develop psychosis. Br J Psychiatry (2008) 1.09
Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res (2007) 1.09
Early intervention in first-episode psychosis--the impact of a community development campaign. Soc Psychiatry Psychiatr Epidemiol (2004) 1.09
Response to "The prevention of schizophrenia: what interventions are safe and effective?". Schizophr Bull (2002) 1.07
The PACE Clinic: identification and management of young people at "ultra" high risk of psychosis. J Psychiatr Pract (2002) 1.07
Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull (2011) 1.07